TAIPEI, TAIWAN--(Marketwired - Jun 21, 2016) - BioBusiness Asia Conference (BBA), Asia's premier business-focused biotechnology conference, will kick off the week-long BioTaiwan 2016, 20 to 24 July, Taipei, Taiwan. In addition to BBA, BioTaiwan 2016 includes the day-long Greater China Opportunities conference, company presentation, one-on-one partnering and an exhibition featuring over 1,300 booths.
Day 1 of BBA 2016 features sessions on the latest trends in global biotechnology development, the potential of Big Data and digital health on drug development and healthcare, and a session on strategies for entering the biologics business. Day Two will feature sessions on new advances in therapeutics including the fast-evolving fields of immuno- and cell therapeutics, how to leverage Taiwan for global drug development, and a session highlighting current trends in partnering and innovative business models. Be a part of this unique gathering and join international speakers from BIO, BioCentury, Pfizer, PriceWaterhouseCoopers, Medtronic, WuXi AppTec, Quintiles, and Millennium Pharmaceuticals, and additionally catch presentations from the leading lights of Taiwan's emerging biotherapeutics sector.
About Taiwan Bio Industry Organization
Taiwan Bio Industry Organization (TBIO) was established in 1989, is the largest and the most influential biotechnology organization in Taiwan. TBIO represents over 300 members ranging from private companies and academic institutes to government bodies involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology. We are a strong arm to foster the development of biotechnology in Taiwan. Our mission is to provide advocacy, business development and communication service for our members.
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=3024635